Last update 19 May 2026

CE211NS21

Overview

Basic Info

Drug Type
Mesenchymal stem cell therapy
Synonyms
Neuromyelitis optica mesenchymal stem cells therapy (CORESTEM), CE 211NS 21, CE-211NS21
Target-
Action-
Mechanism
Cell replacements
Therapeutic Areas
NeoplasmsImmune System DiseasesInfectious Diseases+ [3]
Active Indication
AQP4-IgG positive Neuromyelitis optica spectrum disorderNeuromyelitis Optica
Inactive Indication-
Originator Organization
CORESTEMCHEMON, Inc.CORESTEMCHEMON, Inc.
Active Organization
CORESTEMCHEMON, Inc.CORESTEMCHEMON, Inc.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-

Related

1
Clinical Trials associated with CE211NS21
NCT07595965
/ Not yet recruitingPhase 1
A Phase I Clinical Trial to Evaluate the Safety and Tolerability of Allogeneic Bone Marrow-derived Mesenchymal Stem Cells in Patients With Severe Anti-aqua Porin-4-immunoglobulin G Positive Neuromyelitis Optica Spectrum Disorder Relapse
100 Clinical Results associated with CE211NS21
Login to view more data
100 Translational Medicine associated with CE211NS21
Login to view more data
100 Patents (Medical) associated with CE211NS21
Login to view more data
100 Deals associated with CE211NS21
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
AQP4-IgG positive Neuromyelitis optica spectrum disorderPhase 1-
CORESTEMCHEMON, Inc.CORESTEMCHEMON, Inc.
01 Dec 2026
Neuromyelitis OpticaPreclinical
South Korea
CORESTEMCHEMON, Inc.CORESTEMCHEMON, Inc.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free